Stella Pharma Co., Ltd.
ステラファーマ株式会社
STELLA PHARMA CORPORATION
Alias
Japan
Development of boron drugs used in BNCT (Boron Neutron Capture Therapy)
Manufacturing and sales of boron drugs used in BNCT (Boron Neutron Capture Therapy)
3-2-7 Karasuma, Chuo-ku, Osaka, Osaka Prefecture, ORIX Karasuma Building
Kouji Uehara
3,000,000,000 (30 100 million)
44 people
47 people
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
株式会社産業革新機構(現株式会社INCJ)
Group
海南博鰲(ボアオ)楽城国際医療旅遊先行区
Group
独立行政法人科学技術振興機構(略称 JST)
Group
Loading...
Loading the relationship graph...
21 entries
| Date | Description |
|---|
| 2007-06 |
Established as a 100% subsidiary of Stella Chemifa Co., Ltd. |
| 2007-06-01 |
Establishment. |
| 2008-07 |
Obtained license for manufacturing and sales of type 1 pharmaceuticals (Osaka Prefecture). |
| 2012-11 |
Initiated Phase I clinical trial of SPM-011 for brain tumors in Japan (target patients: recurrent malignant glioma). |
| 2012-11 |
Initiated Phase I clinical trial of SPM-011 for brain tumors in Japan. |
| 2014-01 |
Relocated the research laboratory to the Osaka Prefecture University BNCT Research Center to improve R&D efficiency (Sakai City, Naka-ku). |
| 2014-04 |
Initiated Phase I clinical trial of SPM-011 for head and neck cancer in Japan (target patients: unresectable locally recurrent head and neck cancer and unresectable locally advanced head and neck cancer (non-squamous cell carcinoma)). |
| 2014-04 |
Initiated Phase I clinical trial of SPM-011 for head and neck cancer in Japan. |
| 2016-02 |
Initiated Phase II clinical trial of SPM-011 for brain tumors in Japan (target patients: recurrent malignant glioma). |
| 2016-02 |
Initiated Phase II clinical trial of SPM-011 for brain tumors in Japan. |
| 2016-03 |
Implemented capital increase through a third-party allotment with the Industrial Innovation Organization Inc. (now INCJ) and Sumitomo Heavy Industries as underwriters (Stella Chemifa's voting share decreased to 64%). |
| 2016-03 |
Implemented capital increase through a third-party allotment with the Industrial Innovation Organization Inc. (now INCJ) and Sumitomo Heavy Industries as underwriters. |
| 2016-07 |
Initiated Phase II clinical trial of SPM-011 for head and neck cancer in Japan (target patients: unresectable locally recurrent head and neck cancer and unresectable locally advanced head and neck cancer (non-squamous cell carcinoma)). |
| 2016-07 |
Initiated Phase II clinical trial of SPM-011 for head and neck cancer in Japan. |
| 2017-04 |
SPM-011 designated as a subject item (drug) under the Ministry of Health, Labour and Welfare's pioneering review designation system. |
| 2018-05 |
Established Tokyo office (Chuo-ku, Tokyo). |
| 2020-03 |
Obtained manufacturing and sales approval for BNCT drug Stereobulin® (SPM-011) with indication for 'unresectable locally advanced or locally recurrent head and neck cancer'. |
| 2020-03 |
Obtained manufacturing and marketing approval for the BNCT drug steboronin (SPM-011) for the treatment of unresectable locally advanced or locally recurrent head and neck cancer. |
| 2020-05 |
Commenced sales of BNCT drug Stereobulin®. |
| 2020-05 |
Commenced sales of the BNCT drug steboronin. |
| 2021-04 |
Listed on the Tokyo Stock Exchange Mothers market. |
5120001124194
| Trade name | ステラファーマ株式会社 |
|---|
| Trade name (kana) | ステラファーマ |
|---|
| Name in English | |
|---|
| Corporation type | 301 |
|---|
| Address | 〒541-0043 大阪府大阪市中央区高麗橋３丁目２番７号ＯＲＩＸ高麗橋ビル |
|---|
| Postal code | 5410043 |
|---|
| Prefecture code | 27 |
|---|
| City code | 128 |
|---|
| Address outside Japan | |
|---|
| Prefecture in English | |
|---|
| City in English | |
|---|
| Address outside Japan in English | |
|---|
| Corporate number assignment date | 2015-10-05 |
|---|
| Update date | 2018-07-20 |
|---|
| Change date | 2015-10-05 |
|---|
| Registry closure date | |
|---|
| Reason for registry closure | |
|---|
| Successor corporate number | |
|---|
| Details of the change | |
|---|
| Latest record | 1 |
|---|
| Excluded from search | 0 |
|---|
| Processing type | 01 |
|---|
| Correction type | 1 |
|---|
| Trade name image ID | |
|---|
| Address image ID | |
|---|
| Sequence number | 4204231 |
|---|
Source: National Tax Agency Corporate Number Publication Site, basic three items
5120001124194
| Corporate number | 5120001124194 |
|---|
| Trade name | ステラファーマ株式会社 |
|---|
| Trade name (kana) | ステラファーマ |
|---|
| Trade name (alphabet) | |
|---|
| Registry closure date | |
|---|
| Reason for registry closure | |
|---|
| Registered address | 大阪府大阪市中央区高麗橋３丁目２番７号ＯＲＩＸ高麗橋ビル |
|---|
| Postal code | 5410043 |
|---|
| Prefecture | 大阪府 |
|---|
| Prefecture code | 27 |
|---|
| City or district | 大阪市中央区 |
|---|
| City code | 128 |
|---|
| Street address | 高麗橋３丁目２番７号ＯＲＩＸ高麗橋ビル |
|---|
| Organisation type | 301 |
|---|
| Processing type | 01 |
|---|
| Correction type | 1 |
|---|
| Status | |
|---|
| Representative | 代表取締役社長 上原 幸樹 |
|---|
| Capital | 2859218000 |
|---|
| Employees | 43 |
|---|
| Employees (male) | |
|---|
| Employees (female) | |
|---|
| Business summary | |
|---|
| Website URL | |
|---|
| Year founded | |
|---|
| Business category | |
|---|
| Date established | |
|---|
| Unified government qualification - grade | |
|---|
| Unified government qualification - business items | |
|---|
| Update date | 2018-07-20 |
|---|
| Key information | 5120001124194 |
|---|
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-23 02:49 (Model: gpt-4.1-nano )
